As leading researcher in multiple myeloma, Dr. Phillipe Moreau is head of the unit for early phase 1 and phase 2 trials in clinical hematology at the University Hospital of Nantes and was instrumental in clinical trials for the new proteasome inhibitor ixazomib. Additionally, he was a member of the organizing committee for the 2011 International Myeloma Workshop, in Paris. Dr. Phillipe Moreau is currently a member of the administration council of the Intergroupe Francophone du Myélome (IFM), and he was chairman of the IFM from 2006 through 2009.
University Hospital Hôtel-dieu:
1 Pl. Alexis-Ricordeau, 44000 Nantes, France
Get the latest thought leadership on Myeloma delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life
Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma
Thanks to our HealthTree Community for Myeloma Sponsors: